Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 120 articles: HTML format Text format

Single Articles

August 2018
1. MIRKIN KA, Kulaylat AS, Hollenbeak CS, Messaris E, et al
   Prognostic Significance of Tumor Deposits in Stage III Colon Cancer.
   Ann Surg Oncol. 2018 Aug 6. pii: 10.1245/s10434-018-6661.
   PubMed     Text format     Abstract available
   
   
   July 2018
2. LEE DW, Han SW, Kang JK, Bae JM, et al
   Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
   Ann Surg Oncol. 2018 Jul 30. pii: 10.1245/s10434-018-6681.
   PubMed     Text format     Abstract available
   
   
   
3. MARTIN L, Hopkins J, Malietzis G, Jenkins JT, et al
   Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
   Ann Surg Oncol. 2018 Jul 13. pii: 10.1245/s10434-018-6652.
   PubMed     Text format     Abstract available
   
   
   May 2018
4. OKUNO M, Goumard C, Kopetz S, Vega EA, et al
   RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases.
   Ann Surg Oncol. 2018 May 21. pii: 10.1245/s10434-018-6517.
   PubMed     Text format     Abstract available
   
   
   
5. NARAYANAN S, Kawaguchi T, Yan L, Peng X, et al
   Cytolytic Activity Score to Assess Anticancer Immunity in Colorectal Cancer.
   Ann Surg Oncol. 2018 May 16. pii: 10.1245/s10434-018-6506.
   PubMed     Text format     Abstract available
   
   
   
6. VAN DEN BROEK J, Geenen R, Heijnen L, Kobus C, et al
   Adrenal Incidentalomas During Diagnostic Work-up of Colorectal Cancer Patients: What is the Risk of Metastases?
   Ann Surg Oncol. 2018 May 14. pii: 10.1245/s10434-018-6501.
   PubMed     Text format     Abstract available
   
   
   
7. JACOBSON R, Sherman SK, Dadaleh F, Turaga KK, et al
   Peritoneal Metastases in Colorectal Cancer.
   Ann Surg Oncol. 2018 May 10. pii: 10.1245/s10434-018-6490.
   PubMed     Text format    
   
   
   April 2018
8. BABCOCK BD, Aljehani MA, Jabo B, Choi AH, et al
   High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
   Ann Surg Oncol. 2018 Apr 19. pii: 10.1245/s10434-018-6484.
   PubMed     Text format     Abstract available
   
   
   
9. WEISER MR
   AJCC 8th Edition: Colorectal Cancer.
   Ann Surg Oncol. 2018 Apr 3. pii: 10.1245/s10434-018-6462.
   PubMed     Text format    
   
   
   March 2018
10. SHIDA D, Yoshida T, Tanabe T, Tsukamoto S, et al
    Prognostic Impact of R0 Resection and Targeted Therapy for Colorectal Cancer with Synchronous Peritoneal Metastasis.
    Ann Surg Oncol. 2018 Mar 23. pii: 10.1245/s10434-018-6436.
    PubMed     Text format     Abstract available
    
    
    
11. SIMONEAU E, Vauthey JN
    Progression of Colorectal Cancer Liver Metastasis After Chemotherapy: A New Test of Time?
    Ann Surg Oncol. 2018 Mar 19. pii: 10.1245/s10434-018-6439.
    PubMed     Text format    
    
    
    
12. FLAHERTY DC, Jalas JR, Sim MS, Stojadinovic A, et al
    The Negative Impact of Body Mass Index on the Tumor Microenvironment in Colon Cancer: Results of a Prospective Trial.
    Ann Surg Oncol. 2018 Mar 12. pii: 10.1245/s10434-018-6405.
    PubMed     Text format     Abstract available
    
    
    
13. NAGATA H, Ishihara S, Oba K, Tanaka T, et al
    Development and Validation of a Prediction Model for Postoperative Peritoneal Metastasis After Curative Resection of Colon Cancer.
    Ann Surg Oncol. 2018 Mar 5. pii: 10.1245/s10434-018-6403.
    PubMed     Text format     Abstract available
    
    
    February 2018
14. HOPKINS JJ, Skubleny D, Bigam DL, Baracos VE, et al
    Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.
    Ann Surg Oncol. 2018 Feb 27. pii: 10.1245/s10434-018-6395.
    PubMed     Text format     Abstract available
    
    
    December 2017
15. TAKAHASHI G, Yamada T, Iwai T, Takeda K, et al
    Oncological Assessment of Stent Placement for Obstructive Colorectal Cancer from Circulating Cell-Free DNA and Circulating Tumor DNA Dynamics.
    Ann Surg Oncol. 2017 Dec 12. pii: 10.1245/s10434-017-6300.
    PubMed     Text format     Abstract available
    
    
    November 2017
16. CREASY JM, Sadot E, Koerkamp BG, Chou JF, et al
    The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6264.
    PubMed     Text format     Abstract available
    
    
    
17. DURAES LC, Stocchi L, Steele SR, Kalady MF, et al
    The Relationship Between Clavien-Dindo Morbidity Classification and Oncologic Outcomes After Colorectal Cancer Resection.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6142.
    PubMed     Text format     Abstract available
    
    
    October 2017
18. TIERNAN JP, Jayne DG
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis.
    Ann Surg Oncol. 2017 Oct 31. doi: 10.1245/s10434-017-6200.
    PubMed     Text format    
    
    
    
19. OH BY, Park YA, Huh JW, Yun SH, et al
    Prognostic Impact of Tumor-Budding Grade in Stages 1-3 Colon Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6135.
    PubMed     Text format     Abstract available
    
    
    
20. POVOSKI SP, Hatzaras IS, Mojzisik CM, Arnold MW, et al
    Antigen-Directed Cancer Surgery for Primary Colorectal Cancer: 15-Year Survival Analysis: A Reply.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6201.
    PubMed     Text format    
    
    
    
21. WATANABE K, Salah S, Saito N
    Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6199.
    PubMed     Text format    
    
    
    
22. BINAY SAFER V, Safer U, Yorulmaz E, Sahin Z, et al
    Comment: Skeletal Muscle Depletion is Associated with Severe Postoperative Complications in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Oct 30. doi: 10.1245/s10434-017-6166.
    PubMed     Text format    
    
    
    
23. KLAVER CEL, van Huijgevoort NCM, de Buck van Overstraeten A, Wolthuis AM, et al
    Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases.
    Ann Surg Oncol. 2017 Oct 26. doi: 10.1245/s10434-017-6037.
    PubMed     Text format     Abstract available
    
    
    
24. PASSOT G, Kim BJ, Glehen O, Mehran RJ, et al
    Impact of RAS Mutations in Metastatic Colorectal Cancer After Potentially Curative Resection: Does Site of Metastases Matter?
    Ann Surg Oncol. 2017 Oct 25. doi: 10.1245/s10434-017-6141.
    PubMed     Text format     Abstract available
    
    
    
25. SHIDA D, Tsukamoto S, Ochiai H, Kanemitsu Y, et al
    Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.
    Ann Surg Oncol. 2017 Oct 23. doi: 10.1245/s10434-017-6133.
    PubMed     Text format     Abstract available
    
    
    September 2017
26. CLARKE CN, Lee MS, Wei W, Manyam G, et al
    Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.
    Ann Surg Oncol. 2017 Sep 21. doi: 10.1245/s10434-017-6054.
    PubMed     Text format     Abstract available
    
    
    
27. DEMEY K, Wolthuis A, de Buck van Overstraeten A, Fieuws S, et al
    External Validation of the Prognostic Nomogram (COMPASS) for Patients with Peritoneal Carcinomatosis of Colorectal Cancer.
    Ann Surg Oncol. 2017 Sep 11. doi: 10.1245/s10434-017-6042.
    PubMed     Text format     Abstract available
    
    
    
28. MATSUDA T, Sumi Y, Yamashita K, Hasegawa H, et al
    Anatomy of the Transverse Mesocolon Based on Embryology for Laparoscopic Complete Mesocolic Excision of Right-Sided Colon Cancer.
    Ann Surg Oncol. 2017 Sep 5. doi: 10.1245/s10434-017-6070.
    PubMed     Text format     Abstract available
    
    
    August 2017
29. LORIMER PD, Motz BM, Kirks RC, Boselli DM, et al
    Pathologic Complete Response Rates After Neoadjuvant Treatment in Rectal Cancer: An Analysis of the National Cancer Database.
    Ann Surg Oncol. 2017;24:2095-2103.
    PubMed     Text format     Abstract available
    
    
    
30. WHEALON MD, Gahagan JV, Sujatha-Bhaskar S, O'Leary MP, et al
    Is Fecal Diversion Needed in Pelvic Anastomoses During Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?
    Ann Surg Oncol. 2017;24:2122-2128.
    PubMed     Text format     Abstract available
    
    
    
31. SCHNEIDER MA, Eshmuminov D, Lehmann K
    Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPEC.
    Ann Surg Oncol. 2017;24:2224-2232.
    PubMed     Text format     Abstract available
    
    
    
32. SEEBERG LT, Brunborg C, Waage A, Hugenschmidt H, et al
    Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:2113-2121.
    PubMed     Text format     Abstract available
    
    
    July 2017
33. WATT DG, Ramanathan ML, McSorley ST, Walley K, et al
    Clinicopathological Determinants of an Elevated Systemic Inflammatory Response Following Elective Potentially Curative Resection for Colorectal Cancer.
    Ann Surg Oncol. 2017 Jul 10. doi: 10.1245/s10434-017-5987.
    PubMed     Text format     Abstract available
    
    
    June 2017
34. HA GW, Kim JH, Lee MR
    Oncologic Impact of Anastomotic Leakage Following Colorectal Cancer Surgery: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2017 Jun 12. doi: 10.1245/s10434-017-5881.
    PubMed     Text format     Abstract available
    
    
    
35. YAMASHITA S, Sakamoto Y, Yamamoto S, Takemura N, et al
    Efficacy of Preoperative Portal Vein Embolization Among Patients with Hepatocellular Carcinoma, Biliary Tract Cancer, and Colorectal Liver Metastases: A Comparative Study Based on Single-Center Experience of 319 Cases.
    Ann Surg Oncol. 2017;24:1557-1568.
    PubMed     Text format     Abstract available
    
    
    
36. LIM TZ, Chan DKH, Tan KK
    Endoscopic Stenting Does Not Worsen Long Term Outcomes Amongst Patients Presenting with Obstruction from Colorectal Cancers.
    Ann Surg Oncol. 2017;24:1618-1625.
    PubMed     Text format     Abstract available
    
    
    May 2017
37. D'ANGELICA MI
    Positive Margins After Resection of Metastatic Colorectal Cancer in the Liver: Back to the Drawing Board?
    Ann Surg Oncol. 2017 May 31. doi: 10.1245/s10434-017-5908.
    PubMed     Text format    
    
    
    
38. SIMPSON AL, Doussot A, Creasy JM, Adams LB, et al
    Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer.
    Ann Surg Oncol. 2017 May 30. doi: 10.1245/s10434-017-5896.
    PubMed     Text format     Abstract available
    
    
    
39. YOU YN, Shiozaki H, Lee JE, Passot G, et al
    Total Laparoscopic Management for Stage IV Colorectal Cancer Requiring Multivisceral Resection.
    Ann Surg Oncol. 2017 May 16. doi: 10.1245/s10434-017-5878.
    PubMed     Text format     Abstract available
    
    
    
40. HAWKINS AT, Wells KO, Krishnamurty DM, Hunt SR, et al
    Preoperative Chemotherapy and Survival for Large Anorectal Gastrointestinal Stromal Tumors: A National Analysis of 333 Cases.
    Ann Surg Oncol. 2017;24:1195-1201.
    PubMed     Text format     Abstract available
    
    
    
41. ACHARYA A, Markar SR, Matar M, Ni M, et al
    Use of Tumor Markers in Gastrointestinal Cancers: Surgeon Perceptions and Cost-Benefit Trade-Off Analysis.
    Ann Surg Oncol. 2017;24:1165-1173.
    PubMed     Text format     Abstract available
    
    
    
42. VYCHNEVSKAIA K, Dumont F, Agostini J, Julie C, et al
    Prognostic Value of Sterilized Lymph Nodes After Preoperative Chemoradiotherapy for Patients with ypN0 Rectal Cancer.
    Ann Surg Oncol. 2017;24:1304-1311.
    PubMed     Text format     Abstract available
    
    
    
43. YAMASHITA S, Loyer E, Kang HC, Aloia TA, et al
    Total Transthoracic Approach Facilitates Laparoscopic Hepatic Resection in Patients with Significant Prior Abdominal Surgery.
    Ann Surg Oncol. 2017;24:1376-1377.
    PubMed     Text format     Abstract available
    
    
    
44. DREYER SB, Powell AG, McSorley ST, Waterston A, et al
    The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer.
    Ann Surg Oncol. 2017;24:1295-1303.
    PubMed     Text format     Abstract available
    
    
    
45. KULAYLAT AS, Hollenbeak CS, Stewart DB Sr
    Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
    Ann Surg Oncol. 2017;24:1281-1288.
    PubMed     Text format     Abstract available
    
    
    April 2017
46. CHOULIARAS K, Levine EA, Fino N, Shen P, et al
    Prognostic Factors and Significance of Gastrointestinal Leak After Cytoreductive Surgery (CRS) with Heated Intraperitoneal Chemotherapy (HIPEC).
    Ann Surg Oncol. 2017;24:890-897.
    PubMed     Text format     Abstract available
    
    
    
47. DHIR M, Ramalingam L, Shuai Y, Pakrafter S, et al
    Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases.
    Ann Surg Oncol. 2017;24:875-883.
    PubMed     Text format     Abstract available
    
    
    
48. CHAN CH, Liesenfeld LF, Ferreiro-Neira I, Cusack JC Jr, et al
    Preclinical Evaluation of Cathepsin-Based Fluorescent Imaging System for Cytoreductive Surgery.
    Ann Surg Oncol. 2017;24:931-938.
    PubMed     Text format     Abstract available
    
    
    
49. MEHTA AM, Huitema AD, Burger JW, Brandt-Kerkhof AR, et al
    Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.
    Ann Surg Oncol. 2017;24:990-997.
    PubMed     Text format     Abstract available
    
    
    
50. IHEMELANDU C
    Inflammation-Based Prognostic Scores: Utility in Prognostication and Patient Selection for Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Metastasis of Colonic Origin.
    Ann Surg Oncol. 2017;24:884-889.
    PubMed     Text format     Abstract available
    
    
    
51. IHEMELANDU C, Sugarbaker PH
    Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
    Ann Surg Oncol. 2017;24:898-905.
    PubMed     Text format     Abstract available
    
    
    
52. WRIGHT GP, Marsh JW, Varma MK, Doherty MG, et al
    Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
    Ann Surg Oncol. 2017;24:906-913.
    PubMed     Text format     Abstract available
    
    
    
53. VIGANO L, Lopci E, Costa G, Rodari M, et al
    Positron Emission Tomography-Computed Tomography for Patients with Recurrent Colorectal Liver Metastases: Impact on Restaging and Treatment Planning.
    Ann Surg Oncol. 2017;24:1029-1036.
    PubMed     Text format     Abstract available
    
    
    
54. MACHADO MA, Surjan R, Basseres T, Makdissi F, et al
    Total Laparoscopic Reversal ALPPS.
    Ann Surg Oncol. 2017;24:1048-1049.
    PubMed     Text format     Abstract available
    
    
    March 2017
55. MCSORLEY ST, Roxburgh CS, Horgan PG, McMillan DC, et al
    The Impact of Preoperative Dexamethasone on the Magnitude of the Postoperative Systemic Inflammatory Response and Complications Following Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2017 Mar 1. doi: 10.1245/s10434-017-5817.
    PubMed     Text format     Abstract available
    
    
    
56. WAITE K, Youssef H
    The Role of Neoadjuvant and Adjuvant Systemic Chemotherapy with Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: A Systematic Review.
    Ann Surg Oncol. 2017;24:705-720.
    PubMed     Text format     Abstract available
    
    
    
57. THORGERSEN EB, Goscinski MA, Spasojevic M, Solbakken AM, et al
    Deep Pelvic Surgical Site Infection After Radiotherapy and Surgery for Locally Advanced Rectal Cancer.
    Ann Surg Oncol. 2017;24:721-728.
    PubMed     Text format     Abstract available
    
    
    February 2017
58. ALI SM, Pawlik TM, Rodriguez-Bigas MA, Monson JR, et al
    Timing of Surgical Resection for Curative Colorectal Cancer with Liver Metastasis.
    Ann Surg Oncol. 2017 Feb 21. doi: 10.1245/s10434-016-5745.
    PubMed     Text format     Abstract available
    
    
    
59. CAVNAR MJ, Turcotte S, Katz SC, Kuk D, et al
    Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome.
    Ann Surg Oncol. 2017 Feb 17. doi: 10.1245/s10434-017-5812.
    PubMed     Text format     Abstract available
    
    
    
60. LEE DY, Teng A, Pedersen RC, Tavangari FR, et al
    Racial and Socioeconomic Treatment Disparities in Adolescents and Young Adults with Stage II-III Rectal Cancer.
    Ann Surg Oncol. 2017;24:311-318.
    PubMed     Text format     Abstract available
    
    
    
61. CHOI SH, Choi GH, Han DH, Kwon SW, et al
    Laparoscopic Right Hepatectomy: Toward Protocolization and Simplification.
    Ann Surg Oncol. 2017;24:554-555.
    PubMed     Text format     Abstract available
    
    
    January 2017
62. ALOTAIBI AM, Lee JL, Kim J, Lim SB, et al
    Prognostic and Oncologic Significance of Perineural Invasion in Sporadic Colorectal Cancer.
    Ann Surg Oncol. 2017 Jan 9. doi: 10.1245/s10434-016-5748.
    PubMed     Text format     Abstract available
    
    
    
63. SIOULAS VD, Jorge S, Chern JY, Schiavone MB, et al
    Robotically Assisted Laparoscopic Ovarian Transposition in Women with Lower Gastrointestinal Cancer Undergoing Pelvic Radiotherapy.
    Ann Surg Oncol. 2017;24:251-256.
    PubMed     Text format     Abstract available
    
    
    
64. WIMMER K, Schwarz C, Szabo C, Bodingbauer M, et al
    Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:236-243.
    PubMed     Text format     Abstract available
    
    
    
65. BEPPU N, Kimura F, Aihara T, Doi H, et al
    Patterns of Local Recurrence and Oncologic Outcomes in T3 Low Rectal Cancer (</=5 cm from the Anal Verge) Treated With Short-Course Radiotherapy With Delayed Surgery : Outcomes in T3 Low Rectal Cancer Treated With Short-Course Radiotherapy With Del
    Ann Surg Oncol. 2017;24:219-226.
    PubMed     Text format     Abstract available
    
    
    
66. MARGONIS GA, Sasaki K, Andreatos N, Kim Y, et al
    KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.
    Ann Surg Oncol. 2017;24:264-271.
    PubMed     Text format     Abstract available
    
    
    
67. DHIR M, Jones HL, Shuai Y, Clifford AK, et al
    Hepatic Arterial Infusion in Combination with Modern Systemic Chemotherapy is Associated with Improved Survival Compared with Modern Systemic Chemotherapy Alone in Patients with Isolated Unresectable Colorectal Liver Metastases: A Case-Control Study.
    Ann Surg Oncol. 2017;24:150-158.
    PubMed     Text format     Abstract available
    
    
    
68. ORCUTT ST, Massarweh NN, Li LT, Artinyan A, et al
    Patterns of Care for Colorectal Liver Metastasis Within an Integrated Health System: Secular Trends and Outcomes.
    Ann Surg Oncol. 2017;24:23-30.
    PubMed     Text format     Abstract available
    
    
    December 2016
69. XIE D, Yu C, Gao C, Osaiweran H, et al
    An Optimal Approach for Laparoscopic D3 Lymphadenectomy Plus Complete Mesocolic Excision (D3+CME) for Right-Sided Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
70. NAGATA H, Ishihara S, Hata K, Murono K, et al
    Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
71. KIM JE, Hong YS, Kim HJ, Kim KP, et al
    Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
72. KITAHARA T, Haraguchi N, Takahashi H, Nishimura J, et al
    Identification and Characterization of CD107a as a Marker of Low Reactive Oxygen Species in Chemoresistant Cells in Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
73. WATT DG, McSorley ST, Park JH, Horgan PG, et al
    A Postoperative Systemic Inflammation Score Predicts Short- and Long-Term Outcomes in Patients Undergoing Surgery for Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
74. LISKA D, Stocchi L, Karagkounis G, Elagili F, et al
    Incidence, Patterns, and Predictors of Locoregional Recurrence in Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    October 2016
75. KIM TJ, Kim ER, Hong SN, Kim YH, et al
    Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
76. BECERRA AZ, Aquina CT, Mohile SG, Tejani MA, et al
    Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
77. VAN DE GRAAF FW, Lange MM, Menon AG, O'Mahoney PR, et al
    Erratum to: Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format    
    
    
    
78. KIM CG, Ahn JB, Jung M, Beom SH, et al
    Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
79. VAN DEGRAAF FW, Lange MM, Menon AG, O'Mahoney PR, et al
    Imaging for Quality Control: Comparison of Systematic Video Recording to the Operative Note in Colorectal Cancer Surgery. A Pilot Study.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
80. NAVEZ J, Remue C, Leonard D, Bachmann R, et al
    Surgical Treatment of Colorectal Cancer with Peritoneal and Liver Metastases Using Combined Liver and Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Report from a Single-Centre Experience.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
81. KATAOKA M, Kanda M, Ishigure K, Matsuoka H, et al
    Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format    
    
    
    
82. CIENFUEGOS JA, Martinez P, Baixauli J, Beorlegui C, et al
    Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
83. BECERRA AZ, Berho ME, Probst CP, Aquina CT, et al
    Variation in Hospital-Specific Rates of Suboptimal Lymphadenectomy and Survival in Colon Cancer: Evidence from the National Cancer Data Base.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
84. KATAOKA M, Kanda M, Ishigure K, Matsuoka H, et al
    The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
85. BARATTI D, Kusamura S, Iusco D, Gimondi S, et al
    Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
86. TAN CN, Chong CS, Fong YF, Rauff S, et al
    Laparoscopic Anterior Resection with Transvaginal Specimen Extraction (TVSE) for Colorectal Cancer and Concomitant Total Hysterectomy and Bilateral Salpingo-Oophrectomy (THBSO): A Technical Description.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    July 2016
87. NISHIZAWA Y, Nishida N, Konno M, Kawamoto K, et al
    Clinical Significance of Histone Demethylase NO66 in Invasive Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
88. DURAES LC, Stocchi L, Dietz D, Kalady MF, et al
    The Disproportionate Effect of Perioperative Complications on Mortality within 1 Year After Colorectal Cancer Resection in Octogenarians.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
89. KARANICOLAS PJ, Ko YJ
    Hepatic Arterial Infusion for Unresectable Liver Metastases from Colorectal Cancer: The Dawn of a New Era?
    Ann Surg Oncol. 2016.
    PubMed     Text format    
    
    
    
90. LAO X, Feng Q, He G, Ji M, et al
    Immature Colon Carcinoma Transcript-1 (ICT1) Expression Correlates with Unfavorable Prognosis and Survival in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
91. AMRI R, England J, Bordeianou LG, Berger DL, et al
    Risk Stratification in Patients with Stage II Colon Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    June 2016
92. YAMAMOTO H, Maeda K, Arima H, Sonoda H, et al
    Perioperative Adiponectin Measurement is Useful for Prediction of Postoperative Infection in Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
93. CHEMAMA S, Bayar MA, Lanoy E, Ammari S, et al
    Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
94. SHIDA D, Hamaguchi T, Ochiai H, Tsukamoto S, et al
    Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
95. SUGIMACHI K, Matsumura T, Shimamura T, Hirata H, et al
    Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
96. PATEL D, Townsend AR, Karapetis C, Beeke C, et al
    Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    May 2016
97. LIM C, Doussot A, Osseis M, Salloum C, et al
    Primary Tumor Versus Liver-First Strategy in Patients with Stage IVA Colorectal Cancer: A Propensity Score Analysis of Long-term Outcomes and Recurrence Pattern.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
98. TARANTINO I, Huttner FJ, Warschkow R, Schmied BM, et al
    Prognostic Relevance of Mucinous Subtype in a Population-based Propensity Score Analysis of 40,083 Rectal Cancer Patients.
    Ann Surg Oncol. 2016;23:1576-86.
    PubMed     Text format     Abstract available
    
    
    
99. COLOMBO PE, Bertrand MM, Alline M, Boulay E, et al
    Robotic Versus Laparoscopic Total Mesorectal Excision (TME) for Sphincter-Saving Surgery: Is There Any Difference in the Transanal TME Rectal Approach? : A Single-Center Series of 120 Consecutive Patients.
    Ann Surg Oncol. 2016;23:1594-600.
    PubMed     Text format     Abstract available
    
    
    March 2016
100. LEE SJ, Kang BW, Chae YS, Kim HJ, et al
     Pilot Study of Neoadjuvant Chemoradiotherapy with Three Cycles of 5-Fluorouracil Plus Leucovorin for Treatment of Locally Advanced Rectal Cancer.
     Ann Surg Oncol. 2016;23:894-9.
     PubMed     Text format     Abstract available
     
     
     
101. ROBINSON C, Artinyan A
     Pushing the Limits of Local Excision for Rectal Cancer: Transanal Minimally Invasive Surgery (TAMIS) for Rectal Cancer Using the Port-in-Port Technique.
     Ann Surg Oncol. 2016;23:918.
     PubMed     Text format     Abstract available
     
     
     
102. HUNTINGTON CR, Boselli D, Symanowski J, Hill JS, et al
     Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database.
     Ann Surg Oncol. 2016;23:877-87.
     PubMed     Text format     Abstract available
     
     
     
103. ZIMMITTI G, Soliz J, Aloia TA, Gottumukkala V, et al
     Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases.
     Ann Surg Oncol. 2016;23:1003-11.
     PubMed     Text format     Abstract available
     
     
     
104. LUDMIR EB, Arya R, Wu Y, Palta M, et al
     Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era.
     Ann Surg Oncol. 2016;23:856-62.
     PubMed     Text format     Abstract available
     
     
     
105. MAILLET M, Glehen O, Lambert J, Goere D, et al
     Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study.
     Ann Surg Oncol. 2016;23:863-9.
     PubMed     Text format     Abstract available
     
     
     
106. CHANG SC, Lin PC, Lin JK, Lin CH, et al
     Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.
     Ann Surg Oncol. 2016;23:849-55.
     PubMed     Text format     Abstract available
     
     
     
107. LEOWARDI C, Schneider ML, Hinz U, Harnoss JM, et al
     Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis.
     Ann Surg Oncol. 2016;23:870-6.
     PubMed     Text format     Abstract available
     
     
     
108. SIMKENS GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, et al
     Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis.
     Ann Surg Oncol. 2016;23:833-41.
     PubMed     Text format     Abstract available
     
     
     February 2016
109. MATSUMOTO Y, Tsujimoto H, Ono S, Shinomiya N, et al
     Abdominal Infection Suppresses the Number and Activity of Intrahepatic Natural Killer Cells and Promotes Tumor Growth in a Murine Liver Metastasis Model.
     Ann Surg Oncol. 2016;23 Suppl 2:S257-65.
     PubMed     Text format     Abstract available
     
     
     
110. MAEDA Y, Shinohara T, Nagatsu A, Futakawa N, et al
     Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases.
     Ann Surg Oncol. 2016;23 Suppl 2:S242-8.
     PubMed     Text format     Abstract available
     
     
     
111. KOYAMA M, Murata A, Sakamoto Y, Morohashi H, et al
     Risk Factors for Anastomotic Leakage After Intersphincteric Resection Without a Protective Defunctioning Stoma for Lower Rectal Cancer.
     Ann Surg Oncol. 2016;23 Suppl 2:S249-56.
     PubMed     Text format     Abstract available
     
     
     
112. KENG C, Coates A, Grubac V, Lovrics P, et al
     The Need for Consensus and Transparency in Assessing Population-Based Rates of Positive Circumferential Radial Margins in Rectal Cancer: Data from Consecutive Cases in a Large Region of Ontario, Canada.
     Ann Surg Oncol. 2016;23:397-402.
     PubMed     Text format     Abstract available
     
     
     
113. YAMAMOTO H, Tomita N, Inomata M, Furuhata T, et al
     OSNA-Assisted Molecular Staging in Colorectal Cancer: A Prospective Multicenter Trial in Japan.
     Ann Surg Oncol. 2016;23:391-6.
     PubMed     Text format     Abstract available
     
     
     
114. TOKUNAGA R, Sakamoto Y, Nakagawa S, Miyake K, et al
     The Prognostic Significance of Histone Lysine Demethylase JMJD3/KDM6B in Colorectal Cancer.
     Ann Surg Oncol. 2016;23:678-85.
     PubMed     Text format     Abstract available
     
     
     
115. DOWNS-CANNER S, Magge D, Ravindranathan R, O'Malley ME, et al
     Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer.
     Ann Surg Oncol. 2016;23:655-62.
     PubMed     Text format     Abstract available
     
     
     
116. NISHIGORI N, Koyama F, Nakagawa T, Nakamura S, et al
     Visualization of Lymph/Blood Flow in Laparoscopic Colorectal Cancer Surgery by ICG Fluorescence Imaging (Lap-IGFI).
     Ann Surg Oncol. 2016;23 Suppl 2:S266-74.
     PubMed     Text format     Abstract available
     
     
     
117. YAMADA T, Okabayashi K, Hasegawa H, Tsuruta M, et al
     Age, Preoperative Subcutaneous Fat Area, and Open Laparotomy are Risk Factors for Incisional Hernia following Colorectal Cancer Surgery.
     Ann Surg Oncol. 2016;23 Suppl 2:S236-41.
     PubMed     Text format     Abstract available
     
     
     January 2016
118. WEISER MR
     Rectal Cancer: Time for Precision Medicine?
     Ann Surg Oncol. 2016;23:12-5.
     PubMed     Text format    
     
     
     
119. KULU Y, Tarantino I, Billeter AT, Diener MK, et al
     Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
     Ann Surg Oncol. 2016;23:106-13.
     PubMed     Text format     Abstract available
     
     
     
120. SIMKENS GA, van Oudheusden TR, Braam HJ, Luyer MD, et al
     Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters.
     Ann Surg Oncol. 2016;23:99-105.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: